Compugen Ltd.
CGEN
$1.65
$0.042.48%
Weiss Ratings | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.61 | |||
Price History | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.20% | |||
30-Day Total Return | -29.18% | |||
60-Day Total Return | 3.77% | |||
90-Day Total Return | -3.51% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | -39.56% | |||
2-Year Total Return | 117.97% | |||
3-Year Total Return | -43.49% | |||
5-Year Total Return | -77.18% | |||
52-Week High % Change | -41.07% | |||
52-Week Low % Change | 22.22% | |||
Price | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $2.80 | |||
52-Week Low Price | $1.35 | |||
52-Week Low Price (Date) | Nov 15, 2024 | |||
52-Week High Price (Date) | Mar 18, 2024 | |||
Valuation | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 154.30M | |||
Enterprise Value | 53.95M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.09 | |||
Earnings Per Share Growth | -56.60% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 18.09 | |||
Price/Book (Q) | 2.69 | |||
Enterprise Value/Revenue (TTM) | 6.60 | |||
Price | $1.65 | |||
Enterprise Value/EBITDA (TTM) | -5.06 | |||
Enterprise Value/EBIT | -4.95 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 89.54M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 3 765 8585 | |||
Address | -- | |||
Website | cgen.com | |||
Country | Israel | |||
Year Founded | 1993 | |||
Profitability | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | $0.09 | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -95.60% | |||
Earnings Growth (Q YOY) | -162.98% | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | -163.69% | |||
Balance Sheet | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 103.26M | |||
Cash Per Share (Q) | $1.15 | |||
Total Current Assets (Q) | 106.00M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 54.91M | |||
Current Ratio (Q) | 5.258 | |||
Book Value Per Share (Q) | $0.61 | |||
Total Assets (Q) | 115.00M | |||
Total Current Liabilities (Q) | 20.16M | |||
Total Debt (Q) | 2.91M | |||
Total Liabilities (Q) | 60.08M | |||
Total Common Equity (Q) | 54.91M | |||
Cash Flow | CGEN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||